Cargando…

Early detection of immune checkpoint inhibitor-related subclinical cardiotoxicity: A pilot study by using speckle tracking imaging and three-dimensional echocardiography

BACKGROUND: Early detection of subclinical cardiotoxicity of immune checkpoint inhibitor (ICI) therapy can be challenging. OBJECTIVE: To evaluate subclinical cardiac dysfunction using two-dimensional speckle tracking imaging (2D-STI) and three-dimensional echocardiography in Chinese patients. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Aiqing, Yuan, Ming, Zhan, Xiaoping, Zhao, Gangjian, Mu, Guanyu, Wang, Tingting, Hu, Hailong, Fu, Huaying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812579/
https://www.ncbi.nlm.nih.gov/pubmed/36620612
http://dx.doi.org/10.3389/fcvm.2022.1087287
_version_ 1784863759778447360
author Xu, Aiqing
Yuan, Ming
Zhan, Xiaoping
Zhao, Gangjian
Mu, Guanyu
Wang, Tingting
Hu, Hailong
Fu, Huaying
author_facet Xu, Aiqing
Yuan, Ming
Zhan, Xiaoping
Zhao, Gangjian
Mu, Guanyu
Wang, Tingting
Hu, Hailong
Fu, Huaying
author_sort Xu, Aiqing
collection PubMed
description BACKGROUND: Early detection of subclinical cardiotoxicity of immune checkpoint inhibitor (ICI) therapy can be challenging. OBJECTIVE: To evaluate subclinical cardiac dysfunction using two-dimensional speckle tracking imaging (2D-STI) and three-dimensional echocardiography in Chinese patients. METHODS: Fifty-five consecutive patients with malignant tumors treated by immunotherapy were included. They were examined by echocardiography before immunotherapy and after immunotherapy. Left ventricular ejection fraction (LVEF) was calculated in three-dimensional imaging. Moreover, left ventricular global longitudinal peak systolic strain (LVGLS), left ventricular global circumferential peak systolic strain (LVGCS), right ventricular global longitudinal systolic strain (RVGLS), right ventricular free wall longitudinal peak systolic strain (RVFWLS), and tricuspid annular plane systolic excursion (TAPSE) were evaluated. Clinical and laboratory parameters were recorded. Cardiac toxicity events were defined as the presence of heart failure symptoms, LVEF reduction, and increase in troponin. Subclinical cardiac toxicity was defined as cardiac dysfunction associated with ICI treatment, with absent or delayed ICI-associated cardiotoxicity clinical symptoms. RESULTS: Compared with baseline, the LVGLS, TAPSE, and RVGLS significantly deteriorated after ICI treatment [(–18.63 ± 2.53)% vs. (–17.35 ± 2.58)%, P = 0.000; 18.29 ± 6.23 vs. 14.57 ± 3.81, P = 0.0001; and (–18.45 ± 4.65)% vs. (–14.98 ± 3.85)%, P = 0.0001, respectively]. LVGLS (–17.35 ± 2.58, P = 0.000), TAPSE (14.57 ± 3.81, P = 0.0001), and RVGLS [(–14.98 ± 3.85)%, P = 0.0001] were decreased after ICI immunotherapy. Kaplan-Meier curve analysis showed that LVGLS was more sensitive than the cardiac toxicity events to assess ICI-related subclinical cardiac dysfunction (log-rank P = 0.205). The ROC curve showed that the cutoff value of ΔLVGLS was -13%. CONCLUSION: Subclinical cardiac dysfunction can be detected using two-dimensional speckle-tracking imaging. LVGLS, RVGLS, and TAPSE are more sensitive indices for detection. CLINICAL TRIAL REGISTRATION: [https://www.chictr.org.cn/showprojen.aspx?proj=27498], identifier [ChiCTR1800016216].
format Online
Article
Text
id pubmed-9812579
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98125792023-01-05 Early detection of immune checkpoint inhibitor-related subclinical cardiotoxicity: A pilot study by using speckle tracking imaging and three-dimensional echocardiography Xu, Aiqing Yuan, Ming Zhan, Xiaoping Zhao, Gangjian Mu, Guanyu Wang, Tingting Hu, Hailong Fu, Huaying Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: Early detection of subclinical cardiotoxicity of immune checkpoint inhibitor (ICI) therapy can be challenging. OBJECTIVE: To evaluate subclinical cardiac dysfunction using two-dimensional speckle tracking imaging (2D-STI) and three-dimensional echocardiography in Chinese patients. METHODS: Fifty-five consecutive patients with malignant tumors treated by immunotherapy were included. They were examined by echocardiography before immunotherapy and after immunotherapy. Left ventricular ejection fraction (LVEF) was calculated in three-dimensional imaging. Moreover, left ventricular global longitudinal peak systolic strain (LVGLS), left ventricular global circumferential peak systolic strain (LVGCS), right ventricular global longitudinal systolic strain (RVGLS), right ventricular free wall longitudinal peak systolic strain (RVFWLS), and tricuspid annular plane systolic excursion (TAPSE) were evaluated. Clinical and laboratory parameters were recorded. Cardiac toxicity events were defined as the presence of heart failure symptoms, LVEF reduction, and increase in troponin. Subclinical cardiac toxicity was defined as cardiac dysfunction associated with ICI treatment, with absent or delayed ICI-associated cardiotoxicity clinical symptoms. RESULTS: Compared with baseline, the LVGLS, TAPSE, and RVGLS significantly deteriorated after ICI treatment [(–18.63 ± 2.53)% vs. (–17.35 ± 2.58)%, P = 0.000; 18.29 ± 6.23 vs. 14.57 ± 3.81, P = 0.0001; and (–18.45 ± 4.65)% vs. (–14.98 ± 3.85)%, P = 0.0001, respectively]. LVGLS (–17.35 ± 2.58, P = 0.000), TAPSE (14.57 ± 3.81, P = 0.0001), and RVGLS [(–14.98 ± 3.85)%, P = 0.0001] were decreased after ICI immunotherapy. Kaplan-Meier curve analysis showed that LVGLS was more sensitive than the cardiac toxicity events to assess ICI-related subclinical cardiac dysfunction (log-rank P = 0.205). The ROC curve showed that the cutoff value of ΔLVGLS was -13%. CONCLUSION: Subclinical cardiac dysfunction can be detected using two-dimensional speckle-tracking imaging. LVGLS, RVGLS, and TAPSE are more sensitive indices for detection. CLINICAL TRIAL REGISTRATION: [https://www.chictr.org.cn/showprojen.aspx?proj=27498], identifier [ChiCTR1800016216]. Frontiers Media S.A. 2022-12-21 /pmc/articles/PMC9812579/ /pubmed/36620612 http://dx.doi.org/10.3389/fcvm.2022.1087287 Text en Copyright © 2022 Xu, Yuan, Zhan, Zhao, Mu, Wang, Hu and Fu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Xu, Aiqing
Yuan, Ming
Zhan, Xiaoping
Zhao, Gangjian
Mu, Guanyu
Wang, Tingting
Hu, Hailong
Fu, Huaying
Early detection of immune checkpoint inhibitor-related subclinical cardiotoxicity: A pilot study by using speckle tracking imaging and three-dimensional echocardiography
title Early detection of immune checkpoint inhibitor-related subclinical cardiotoxicity: A pilot study by using speckle tracking imaging and three-dimensional echocardiography
title_full Early detection of immune checkpoint inhibitor-related subclinical cardiotoxicity: A pilot study by using speckle tracking imaging and three-dimensional echocardiography
title_fullStr Early detection of immune checkpoint inhibitor-related subclinical cardiotoxicity: A pilot study by using speckle tracking imaging and three-dimensional echocardiography
title_full_unstemmed Early detection of immune checkpoint inhibitor-related subclinical cardiotoxicity: A pilot study by using speckle tracking imaging and three-dimensional echocardiography
title_short Early detection of immune checkpoint inhibitor-related subclinical cardiotoxicity: A pilot study by using speckle tracking imaging and three-dimensional echocardiography
title_sort early detection of immune checkpoint inhibitor-related subclinical cardiotoxicity: a pilot study by using speckle tracking imaging and three-dimensional echocardiography
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812579/
https://www.ncbi.nlm.nih.gov/pubmed/36620612
http://dx.doi.org/10.3389/fcvm.2022.1087287
work_keys_str_mv AT xuaiqing earlydetectionofimmunecheckpointinhibitorrelatedsubclinicalcardiotoxicityapilotstudybyusingspeckletrackingimagingandthreedimensionalechocardiography
AT yuanming earlydetectionofimmunecheckpointinhibitorrelatedsubclinicalcardiotoxicityapilotstudybyusingspeckletrackingimagingandthreedimensionalechocardiography
AT zhanxiaoping earlydetectionofimmunecheckpointinhibitorrelatedsubclinicalcardiotoxicityapilotstudybyusingspeckletrackingimagingandthreedimensionalechocardiography
AT zhaogangjian earlydetectionofimmunecheckpointinhibitorrelatedsubclinicalcardiotoxicityapilotstudybyusingspeckletrackingimagingandthreedimensionalechocardiography
AT muguanyu earlydetectionofimmunecheckpointinhibitorrelatedsubclinicalcardiotoxicityapilotstudybyusingspeckletrackingimagingandthreedimensionalechocardiography
AT wangtingting earlydetectionofimmunecheckpointinhibitorrelatedsubclinicalcardiotoxicityapilotstudybyusingspeckletrackingimagingandthreedimensionalechocardiography
AT huhailong earlydetectionofimmunecheckpointinhibitorrelatedsubclinicalcardiotoxicityapilotstudybyusingspeckletrackingimagingandthreedimensionalechocardiography
AT fuhuaying earlydetectionofimmunecheckpointinhibitorrelatedsubclinicalcardiotoxicityapilotstudybyusingspeckletrackingimagingandthreedimensionalechocardiography